Healthtech Startups

MediSage builds digital health technology connecting doctors, patients and healthcare organizations, offering AI-powered clinical decision support, voice-enabled documentation, evidence-based medical education, and patient care tools for nutrition and monitoring. It serves healthcare professionals, patients, and healthcare companies across Asia.

1 investor

MyMeds provides real-time data analytics and member engagement platforms for health plans to improve medication adherence, close care gaps, and optimize Star ratings performance. The platform serves Medicare Advantage plans and other value-based care organizations managing populations with chronic conditions.

1 investor

My Mobile MD provides mobile physician services with onsite providers to deliver primary and urgent care directly to patients, emphasizing personalized treatment plans and direct provider relationships outside traditional healthcare settings.

1 investor

Telemynd is a mental healthcare platform that connects patients with licensed providers through a human-centered approach, prioritizing privacy and continuity of care while using technology to reduce administrative burden and improve access.

1 investor

myNEO provides AI-powered software for drug discovery and development, specifically targeting antibody, bispecific, ADC, cell therapy, vaccine, and neoantigen-based immunotherapy programs. The company serves pharmaceutical and biotech organizations across target discovery, optimization, and data analysis stages.

1 investor

Mynurva delivers mental health support services for employees, organizations, universities, and charities, combining clinical expertise with digital platforms to make therapy accessible across the UK and MENA region.

1 investor

MYOLYN develops Functional Electrical Stimulation (FES) technology that helps users activate muscles, build strength, and improve movement. Its systems serve people with paralysis, rehabilitation patients, active adults, and athletes across home, clinical, and training settings.

1 investor

Myomo develops wearable robotic orthoses to restore arm and hand function for individuals with limited mobility due to stroke, brachial plexus injury, or spinal cord injury. The company serves patients and healthcare providers in the medical device and rehabilitation markets.

1 investor

Cadre Bioscience partners with innovators to develop and bring new therapeutics to clinical application through drug development.

1 investor

Myontec develops wearable technology (MShorts Plus and MSleeves) that monitors muscle activation and load in real time across quadriceps, hamstrings, glutes, and adductors for team sports athletes and coaches focused on performance optimization and injury prevention.

1 investor

Myopia AI is developing an AI-based solution using proprietary models and biologically-based algorithms to stop the progression of myopia (nearsightedness) in children and adults. The company operates in vision health technology, addressing the growing prevalence of myopia and its associated eye-disease risks.

1 investor

Myoptechs develops treatments and interventions for myopia, a progressive eye disease that causes worsening distance vision and can lead to sight-threatening complications. The company targets patients and their eye care providers seeking to reduce both short- and long-term vision complications from myopia.

1 investor

Myospan develops smarter protein systems and science-based guidance focused on muscle longevity and healthy aging, targeting adults 35+ who want to maintain strength, recovery, and mobility. It offers a coaching program (the Muscle Longevity System), a podcast, and educational guides on nutrition, amino acids, and resistance training.

1 investor

myPharmacy is a service provider that supports pharmacies across operational areas including controlling tools, quality management, marketing, and staff development. It has served pharmacies in Germany since 2006.

1 investor

Myriad Genetics is a genetic testing and precision medicine company that delivers molecular diagnostic test results across hereditary cancer risk, reproductive health, oncology, urology, and mental health. It serves patients and healthcare providers with insights to help detect, treat, and prevent disease.

1 investor

MyRNA offers cancer risk screening, positioning it as part of broader healthcare and care conversations. The company participates in healthcare industry events in Malaysia, including the Selangor International Care Expo.

1 investor

MySecondEar is Germany's leading digital hearing aid provider, offering hearing devices, accessories, and professional fitting services both online and at physical locations. The company serves customers seeking accessible, transparent hearing solutions through a combination of digital and in-person support.

1 investor

MySwimPro provides personalized swim training and coaching through mobile and wearable apps for swimmers worldwide. The platform combines fitness technology with swim coaching expertise to help users improve their swimming ability and achieve their fitness goals.

1 investor

MyTrials provides a platform helping patients and families navigate and find clinical trials through AI-driven technology. The service addresses the complexity of trial discovery for individuals seeking medical research participation opportunities.

1 investor

MyUTI is a platform providing UTI testing and support services for women with frequent and stubborn urinary tract infections. The company addresses gaps in women's health diagnostics and treatment by offering reliable testing solutions and clinical guidance.

1 investor

My Well Self is an online wellness care navigation platform that bridges conventional and complementary medicine to improve health outcomes and reduce preventable chronic conditions for individuals, employers, and governments.

1 investor

N.B. Medical develops neurovascular medical devices combined with in-house regulation-integrated computational modeling and simulation (CMS), AI-driven documentation, and digital-twin technologies such as virtual stent deployment via a proprietary finite-element solver. Based in Japan, it aims to accelerate precise, regulation-ready medical device development.

1 investor

Nabsys develops genome mapping technology for genomic structural variant analysis, enabling precision and cost-effectiveness in this field. The company serves research and clinical customers globally.

1 investor

Based on the page listing "Ophthalmic Pharmaceutical Consultant" and "Chief Clinical Officer" roles, Nacuity appears to be a pharmaceutical company focused on ophthalmology (eye care), though the page provides insufficient detail to confirm products, customer base, or market focus.

1 investor